DOCSLIB.ORG

Liddle's Syndrome)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Liddle's Syndrome) Endocrinol. Japon. 1989, 36(1), 167-173 NOTE Plasma Aldosterone Level in a Female Case of Pseudohyperaldosteronism (Liddle's Syndrome) KAZUHISA TAKEUCHI, KEISHI ABE*, MAKITO SATO, MINORU YASUJIMA, KEN OMATA, OSAMU MURAKAMI AND KAORU YOSHINAGA Second Department of Internal Medicine, and *Department of Clinical Biology and Hormonal Regulation, Tohoku University, School of Medicine, 1-1 Seiryo-cho, Sendai 980, Japan Abstract A 22-yr-old female suffering from hypertension, hypokalemic alkalosis and suppressed plasma renin activity was studied. The plasma aldosterone con- centration (PAC) ranged between subnormal and normal levels while the other adrenal mineralocorticoids were normal. Examinations through computed. tomography and ultrasonography showed no abnormal findings. For dif- erential diagnosis, dexamethasone, spironolactone and triamterene were ad- ministered. Triamterene alone corrected the abnormalities in this case, and the therapeutic effect was further enhanced by sodium restriction. There- fore, the present case is strongly suggested to be one of Liddle's syndrome, which is characterized by a primary defect in renal tubular sodium handling and can be corrected with triamterene. However, the patient in our study is different from the first reported case in which aldosterone secretion was estimated to be low. Analysis of the changes in PAC has shown that PAC is parallel with the level of plasma progesterone in accordance with the rhythm of the menstrual cycle and, in the follicular phase, PAC is rather low. It is concluded that the patient was suffering from Liddle's syndrome, and it is assumed that PAC is not always subnormal and, as same as in normal females, PAC may change in accordance with the rhythm of the menstrual cycle in a female case of Liddle's syndrome. Pseudohyperaldosteronism is characteriz- either aldosterone or other endogenous ed by hypertension, hypokalemia and hy- mineralocortico id excess (Biglieri, 1981; poreninemia, suggesting a diagnosis of Sebastian et al., 1982). This state is brought primary aldosteronism. However, pseudo- about by several factors, including the hyperaldosteronism is not associated with administration of synthetic mineralocorti- coids, and the ingestion of substances Received September 22, 1988 causing mineralocorticoid-like activity, as Address correspondence to KAZUHISA TAKE- UCHI, M. D., Second Department of Internal well as Liddle's syndrome. Liddle's syn- Medicine, Tohoku University, School of Medi- drome is markedly different from the other cine, 1-1 Seiryo-cho, Sendai 980, Japan conditions, because its synptoms are not Endocrinol. Japon. 168 TAKEUCHI et al. February 1989 due to the renal action of mineralocorticoid was again confirmed. In spite of the but to a primary defect in renal sodium- administration of a calcium antagonist , potassium handling in renal distal tubules. nifedipine 60mg/day, and a potassium The present case was considered to be a supplement of K+ 24mEq/day, the abnor- case of Liddle's syndrome, although the malities persisted and she was referred to plasma aldosterone concentration (PAC) was our department for a thorough examination. not consistantly subnormal. We evaluated It was determined that she had no history the change in PAC in relation to the men- of excessive licorice ingestion, steroid hor- strual cycle and demonstrated a close rela- mone abuse or use of contraceptives. tionship between them. A physical examination showed the patient to be a phenotypically normal female, 160cm in height, weighing 50kg , Case Report and having no abnormal skin pigmentation . She had normal secondary sexual character- A 22-yr-old female suffering from hy- istics and a regular menstrual cycle. Her pertension and hypokalemia was admitted menarche had occurred at age 12. Blood to our department. She had been complain- pressure ranged between 200/120 and 150/ ing of recurrent headaches and general 100mmHg. Her chest X-ray was normal . muscular weakness for several years. An However, electrocardiography revealed left aunt (on her mother's side of the family) ventricular hypertrophy, and fundoscopic had died suddenly of an unkown etiology examination revealed mild ateriolar thicken- at the age of 35, and an uncle , on the ing. Her serum sodium level was found to same side, had died of kidney disease with be 144mEq/L and serum potassium 2.6 edema at age 5. mEq/L (normal value; 3.4-4.2mEq/L). Eight years before admission to our Arterial blood gas analysis showed the department, a school examination had dis- following: PH, 7.47; standard bicarbonate, closed that the patient was suffering from 30.8mmol/L; pCO2, 44.1mmHg; pO2, 88.0 high blood pressure (180/110mmHg) . At mmHg; and base excess, + 7.2mEq/L. that time, she was referred to the depart- Blood urea nitrogen was found to be 12 ment of pediatrics of a general hospital . and creatinine 1.1mg/dl. A complete Tests showed that she had hypertension blood count, urinalysis, and measurements (blood pressure ranged between 190/130 of serum concentrations of calcium, phos- and 170/100mmHg), hypokalemia (serum phorus, magnesium, albumin, globulin, potassium 2.8mEq/L). Plasma renin activity glucose, uric acid, lactic dehydrogenase, (PRA) was low and the plasma aldosterone glutamic-oxaloacetic transaminase and cho- concentration (PAC) was in the high-normal lesterol were done. All were found to be range. A tentative diagnosis of primary within normal limits. Creatinine clearance aldosteronism was made, and 75mg/day of was 73ml/min and para-amino hippuric spironolactone was administered. However, acid clearance 468ml/min. The findings her headaches persisted and the other ab- of travenous pyelography were normal. normal findings remained. After a few Urinary catecholamines, 17-ketosteroids (17- months, she refused to take the medication KS) and 17-hydroxycorticosteroids (17- and terminated her hospital visits. A few OHCS) were normal. PRA was undetec- months before admission to our department, table (<2.5ng/ml/6hr; normal value: 5- she visited a physician due to a common 30ng/ml/6hr), PAC was low within normal cold. At that time, her blood pressure was limits (2.4 ng/dl; normal value: 2-12ng/dl). found to be 180/100mmHg and hypokalemia Adrenal scintigram with 131I-adosterol (6ƒÀ- Vol. 36, No. 1 PLASMA ALDOTERONE LEVELS IN LIDDLE'S SYNDROME 169 iodomethyl-19-nor- cholest-5 (10)-en-3ƒÀ-ol, 80mEq/day. Daiichi Radioisotopes Laboratories Ltd., Blood pressure was measured with a standard sphygmomanometer at 0600h in recumbency Tokyo) showed diffuse accumulation of 131I every day. Plasma ACTH, aldosterone, cortisol, on bilateral adrenals and the uptake of 131I progesterone, corticosterone, deoxycorticosterone almost disappeared with the administration (DOC) and 18-hydroxy-deoxycorticosterone (18- of dexamethasone. Examinations through OH-DOC) were measured by radioimmunoassay echosonography and computed tomo- using commercially available kits (Dinabot Co., graphy showed normal findings in the Tokyo). PRA was measured by radioimmuno- abdomen. assay of angiotensin I as previously reported These data were not consistent with the (Abe et al., 1973). 19-hydroxyandrostenedione was measured by Dr. Sekihara of Tokyo Uni- usual findings in primary aldosteronism. versity. Therefore, further diagnostic examinations, including administration of dexamethasone, spironolactone and triamterene were carried Results out. Baseline Condition (Fig. 1) Methods High blood pressure persisted during this period. Serum potassium was 2.6 All examinations were carried out during 4 mEq/L. Urinary excretion of potassium months' hospitalization. The patient recieved a was above 50mEq/day, suggesting the salt restricted diet containing less than 5g NaCl kidney's inability to conserve potassium. (Na+ 85mEq)/day for a full month; for the PRA was undetectable during the furosemide remainder of her stay, she recieved a regular test. PAC was normal (5.8ng/dl) and diet containing 12g NaCl (Na+ 200mEq)/day constant during the furosemide test. Corti- and K+ 80 mEq/day. During hospitalization, 60 mg nifidipine and 50mg/day atenolol had to be costerone, DOC and 18-OH-DOC were all administered to prevent a hypertensive crisis, within normal limits. Urinary 17-OHCS because high blood pressure and complaints of and 17-KS excretions were normal. The headache persisted following admission. In a basal plasma cortisol level (8.0ƒÊg/dl) was furosemide test, blood samples were collected normal (normal value: 5-16 ƒÊg/dl) and to measure PRA and PAC after the patient had showed a normal response to the rapid stood upright for one and two hours, respec- ACTH test, because the basal plasma tively, following the intravenous injection of furosemide 60mg. A rapid ACTH test was cortisol level was increased to 17.3, 17.4 performed by intravenous injection of 250ƒÊg of and 24.5ƒÊg/dl at 30, 60 or 90min after α1-24ACTH(Cortrosyn: Daiichi Co., Tokyo), the injection of ACTH, respectively. In the as well as a dexamethasone, supression test by dexamethasone (Dx.) suppression test, the means of the oral administration of either 1 or basal plasma cortisol (5.4ƒÊg/dl) was de- 8mg of dexamethasone. Four studies on meta- creased to an undetectable level either by bolic balance were carried out to examine changes in blood pressure and renal electrolyte Dx. 1mg or Dx. 8mg, indicating a normal excretion in response to: 1) inhibition of adrenal response, whereas PAC showed a very weak biosynthesis by dexamethasone 2mg/day for 2 response to both a stimulatory and an in- weeks; 2) administration of triamterene 100 and hibotory procedure. In the rapid ACTH 200mg/day for 3 weeks; 3) administration of test, the basal PAC (8.0ng/dl) was not triamterene 200mg/day and salt restriction (Nat changed significantly at 30 min (8.5ng/dl), 85mEq/day) and, 4) blockade of mineralocorti- coid hormone receptors using 150 and 300mg/ 60min (9.3ng/dl) or 90min (10.1ng/dl) day spironolactone for 2 weeks. During these after the injection of ACTH, and in the Dx. periods dietary potassium was kept at around suppression test, the basal PAC (9.6ng/dl) Endocrinol. Japon. 170 TAKEUCHI et al.
Load more

Recommended publications
  • Familial Hyperaldosteronism
    Familial hyperaldosteronism Description Familial hyperaldosteronism is a group of inherited conditions in which the adrenal glands, which are small glands located on top of each kidney, produce too much of the hormone aldosterone. Aldosterone helps control the amount of salt retained by the kidneys. Excess aldosterone causes the kidneys to retain more salt than normal, which in turn increases the body's fluid levels and blood pressure. People with familial hyperaldosteronism may develop severe high blood pressure (hypertension), often early in life. Without treatment, hypertension increases the risk of strokes, heart attacks, and kidney failure. Familial hyperaldosteronism is categorized into three types, distinguished by their clinical features and genetic causes. In familial hyperaldosteronism type I, hypertension generally appears in childhood to early adulthood and can range from mild to severe. This type can be treated with steroid medications called glucocorticoids, so it is also known as glucocorticoid-remediable aldosteronism (GRA). In familial hyperaldosteronism type II, hypertension usually appears in early to middle adulthood and does not improve with glucocorticoid treatment. In most individuals with familial hyperaldosteronism type III, the adrenal glands are enlarged up to six times their normal size. These affected individuals have severe hypertension that starts in childhood. The hypertension is difficult to treat and often results in damage to organs such as the heart and kidneys. Rarely, individuals with type III have milder symptoms with treatable hypertension and no adrenal gland enlargement. There are other forms of hyperaldosteronism that are not familial. These conditions are caused by various problems in the adrenal glands or kidneys. In some cases, a cause for the increase in aldosterone levels cannot be found.
    [Show full text]
  • Primary Aldosteronism: a Common Cause of Resistant Hypertension
    REVIEW CPD Primary aldosteronism: a common cause of resistant hypertension Gregory A. Kline MD, Ally P.H. Prebtani BScPhm MD, Alexander A. Leung MD, Ernesto L. Schiffrin CM MD PhD n Cite as: CMAJ 2017 June 5;189:E773-8. doi: 10.1503/cmaj.161486 esistant or difficult-to-control hypertension is a problem that may affect as many as 13% of all persons with hyper- KEY POINTS tension.1 It is estimated that more than 6 million (22.6%) • Difficult-to-control hypertension should trigger testing for primary Rof adults in Canada have hypertension, but less than two-thirds aldosteronism. have it adequately controlled despite conventional strategies for Measurement of aldosterone-to-renin ratio (ARR) is the preferred 2 • treatment. Uncontrolled hypertension may arise from nonadher- diagnostic test. ence to medication, selection of suboptimal treatment regimens • Patients with high ARR who are potential candidates for surgical and/or the presence of unidentified secondary causes. It is frus- adrenalectomy and those with severe hypertension for whom trating for both the patient and treating physician. Patients may discontinuation of antihypertensive drugs would be dangerous embark upon a series of variably successful approaches with dif- should be referred to a hypertension specialist for assessment. ferent drug classes. We review the accumulating epidemiologic • Patients with very severe hypertension who may not tolerate drug evidence on primary aldosteronism and hypertension that is adjustment for ARR measures should also be assessed by a hypertension specialist. resistant to treatment. We offer a pragmatic approach to diagno- sis for generalist physicians. Although no randomized controlled • Patients who cannot be considered for adrenalectomy may consider an empiric trial of spironolactone or eplerenone for blood pressure control.
    [Show full text]
  • Primary Aldosteronism—Not Just About Potassium and Blood Pressure
    QJM: An International Journal of Medicine, 2017, 175–177 doi: 10.1093/qjmed/hcw224 Advance Access Publication Date: 9 January 2017 Case report CASE REPORT Primary aldosteronism—not just about potassium and Downloaded from https://academic.oup.com/qjmed/article-abstract/110/3/175/2875723 by guest on 27 November 2019 blood pressure T.H. Toh, C.V. Tong and H.C. Chong From the Department of Internal Medicine, Malacca General Hospital, Malacca, Malaysia Address correspondence to T.H. Toh, Department of Internal Medicine, Malacca General Hospital, Malacca, Malaysia. email: [email protected] She presented again in the subsequent years with body Learning point for clinicians weakness, recurrent low electrolyte levels and was hyperten- sive. Gitelman or Bartter syndrome was considered initially due Primary aldosteronism is one of the few potentially cur- to certain overlapping features. The development of hyperten- able causes of hypertension and it requires a high index of suspicion in making an accurate diagnosis. This case sion later prompted the investigation for hyperaldosteronism. illustrates the importance of looking at electrolytes other Phaechromocytoma and Cushing’s syndrome were also ruled than just the potassium in a patient with severe primary out. We performed an aldosterone renin ratio, followed by a sa- aldosteronism. line suppression test. Patient was on prazosin and verapamil when these tests were carried out and had serum potassium >4 mmol/l with potassium supplements. Her laboratory results are in Table 1. Computed tomography of the adrenal showed a well defined Introduction hypodense lesion in the medial limb of the left adrenal gland Primary aldosteronism is a well established cause of secondary measuring 2.5 Â 1.6 Â 1.6 cm.
    [Show full text]
  • Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic Paradigm
    Kidney360 Publish Ahead of Print, published on July 23, 2020 as doi:10.34067/KID.0000922020 Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic Paradigm Michael R Lattanzio(1), Matthew R Weir(2) (1) Division of Nephrology, Department of Medicine, The Chester County Hospital/University of Pennsylvania Health System (2) Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD Correspondence: Matthew R Weir University of Maryland Medical Center Division of Nephrology 22 S. Greene St. Room N3W143 Baltimore, Maryland 21201 [email protected] 1 Copyright 2020 by American Society of Nephrology. Abbreviations PA=Primary Hyperaldosteronism CVD=Cardiovascular Disease PAPY=Primary Aldosteronism Prevalence in Hypertension APA=Aldosterone-Producing Adenoma BAH=Bilateral Adrenal Hyperplasia ARR=Aldosterone Renin Ratio AF=Atrial Fibrillation OSA=Obstructive Sleep Apnea OR=Odds Ratio AHI=Apnea Hypopnea Index ABP=Ambulatory Blood Pressure AVS=Adrenal Vein Sampling CT=Computerized Tomography MRI=Magnetic Resonance Imaging SIT=Sodium Infusion Test FST=Fludrocortisone Suppression Test CCT=Captopril Challenge Test PAC=Plasma Aldosterone Concentration PRA=Plasma Renin Activity MRA=Mineralocorticoid Receptor Antagonist MR=Mineralocorticoid Receptor 2 Abstract Nearly seven decades have elapsed since the clinical and biochemical features of Primary Hyperaldosteronism (PA) were described by Conn. PA is now widely recognized as the most common form of secondary hypertension. PA has a strong correlation with cardiovascular disease and failure to recognize and/or properly diagnose this condition has profound health consequences. With proper identification and management, PA has the potential to be surgically cured in a proportion of affected individuals. The diagnostic pursuit for PA is not a simplistic endeavor, particularly since an enhanced understanding of the disease process is continually redefining the diagnostic and treatment algorithm.
    [Show full text]
  • Reduced Na+,K+-Atpase Activity in Patients with Pseudohypoaldosteronism
    0031-399819413503-0372$03.00/0 PEDIATRIC RESEARCH Vol. 35, No. 3. 1994 Copyright O 1994 International Pediatric Research Foundation, Inc. Prinrc7d in U.S. A. Reduced Na+,K+-ATPase Activity in Patients with Pseudohypoaldosteronism TZW BISTRITZER, SANDRA EVANS, DITA COTARIU, MICHAEL GOLDBERG, AND MORDECHAI ALADJEM Departments of Pediatrics [T.B., hf.A.1, Bioche~nicalPathology [S.E., D.C.], and Neonatology [Jf.G.], Assaf Harofeh hfedical Center, Sackler Faclclty ofhfedicine, TeI Aviv University, Zerfi~i70300. Israel ABSTRACT. Pseudohypoaldosteronism is a hereditary wasting syndrome varies widely with age and is particularly salt-wasting syndrome usually seen in infancy with weight severe in infancy. Spontaneous improvement in sodium conser- loss, dehydration, and failure to thrive. The patho- vation occurs as the individuals become older. Aldosterone de- physiologic origin of pseudohypoaldosteronism is un- ficiency in the face of overproduction of zona glomerulosa 18- known. The defect could be related to the unresponsiveness hydroxycorticosterone (10) was found, an abnormality for which of target organs to mineralocorticoids resulting in hypo- the term type 2 corticosterone methyl-oxidase defect was coined natremia, hyperkalemia, and markedly elevated plasma (1 1). Treatment with mineralocorticoids and high-sodium diet aldosterone and renin levels. Red blood cell Na+,K+-ATP reduces the secretion of the aldosterone precursor, restores elec- ase activity was measured in a pair of twins with pseudo- trolyte balance, and normalizes the growth rate (3). hypoaldosteronism, in an unrelated child with hypoaldos- Little information has been added in regard to the patho- teronism, and in an age-matched group of 50 healthy physiologic expression of PHA since its original description by infants and young children.
    [Show full text]
  • Primary Aldosteronism, a Common Entity? the Myth Persists
    Journal of Human Hypertension (2002) 16, 159–162 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh REVIEW ARTICLE Primary aldosteronism, a common entity? the myth persists PL Padfield Department of Medical Sciences, Western General Hospital, University of Edinburgh, Scotland, UK Primary aldosterone excess or hyperaldosteronism is aldosterone is in fact inappropriately elevated if the an important cause of hypertension which, when asso- renin level is low. A single measurement of the ratio of ciated with an aldosterone secreting adenoma, is amen- aldosterone to renin levels is claimed to be highly pre- able to surgical cure. The biochemical hallmarks of the dictive of patients who will have primary aldosterone condition are a relative excess of aldosterone pro- excess. This paper examines the logic behind such duction with suppression of plasma levels of renin (a claims and presents evidence from the literature that an proxy for angiotensin II, the major trophic substance abnormal ratio is simply a different description of the regulating aldosterone secretion). This combination of low renin state and that such patients do not necessarily a high aldosterone and a low renin is however more have mineralocorticoid hypertension. Most patients ‘dis- commonly associated with ‘nodular hyperplasia’ of the covered’ by this test will have what many call low-renin adrenal glands, a condition not improved by surgery hypertension, a condition not amenable to specific ther- and variably responsive to the effects of the mineral- apy. Claims that they are peculiarly sensitive to the ocorticoid antagonist, spironolactone. Until recently the hypotensive effects of spironolactone have not been prevalence of either form of secondary hypertension tested in controlled trials.
    [Show full text]
  • Primary Hyperaldosteronism: a Case of Unilateral Adrenal Hyperplasia with Contralateral Incidentaloma Sujit Vakkalanka,1 Andrew Zhao,1 Mohammed Samannodi2
    Unexpected outcome (positive or negative) including adverse drug reactions CASE REPORT Primary hyperaldosteronism: a case of unilateral adrenal hyperplasia with contralateral incidentaloma Sujit Vakkalanka,1 Andrew Zhao,1 Mohammed Samannodi2 1University at Buffalo, Buffalo, SUMMARY palpitations or any difficulty breathing in the past. New York, USA Primary hyperaldosteronism is one of the most common She was being managed in an outpatient setting for 2Department of Medicine, Buffalo, New York, USA causes of secondary hypertension but clear hypokalaemia and hypertension since 2009. She differentiation between its various subtypes can be a has been taking three antihypertensives (amlodi- Correspondence to clinical challenge. We report the case of a 37-year-old pine, benazepril and labetalol) and supplemental Dr Mohammed Samannodi, African-American woman with refractory hypertension potassium (2 tablets of 10 mEq three times a day) [email protected] who was admitted to our hospital for palpitations, but was very recently switched to hydralazine, ver- Accepted 28 June 2016 shortness of breath and headache. Her laboratory results apamil and doxazosin mesylate, and two potassium showed hypokalaemia and an elevated aldosterone/renin tablets of 20 mEq three times a day. ratio. An abdominal CT scan showed a nodule in the left On physical examination, her heart rate was adrenal gland but adrenal venous sampling showed 110 bpm while the blood pressure was 170/ elevated aldosterone/renin ratio from the right adrenal 110 mm Hg. Cardiac, abdominal, neurological and vein. The patient began a new medical regimen but musculoskeletal examinations were unimpressive declined any surgical options. We recommend with no signs of clubbing or oedema.
    [Show full text]
  • The Expanding Genetic Horizon of Primary Aldosteronism
    3 178 S Monticone and others Genetics of primary 178:3 R101–R111 Review aldosteronism GENETICS IN ENDOCRINOLOGY The expanding genetic horizon of primary aldosteronism Silvia Monticone1, Fabrizio Buffolo1, Martina Tetti1, Franco Veglio1, Barbara Pasini2 and Paolo Mulatero1 Correspondence should be addressed 1Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Torino, to P Mulatero Italy and 2Division of Medical Genetics, Department of Medical Sciences, University of Torino, Torino, Italy Email [email protected] Abstract Aldosterone is the main mineralocorticoid hormone in humans and plays a key role in maintaining water and electrolyte homeostasis. Primary aldosteronism (PA), characterized by autonomous aldosterone overproduction by the adrenal glands, affects 6% of the general hypertensive population and can be either sporadic or familial. Aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia (BAH) are the two most frequent subtypes of sporadic PA and 4 forms of familial hyperaldosteronism (FH-I to FH-IV) have been identified. Over the last six years, the introduction of next-generation sequencing has significantly improved our understanding of the molecular mechanisms responsible for autonomous aldosterone overproduction in both sporadic and familial PA. Somatic mutations in four genes (KCNJ5, ATP1A1, ATP2B3 and CACNA1D), differently implicated in intracellular ion homeostasis, have been identified in nearly 60% of the sporadic APAs. Germline mutations in KCNJ5 and CACNA1H cause FH-III and FH-IV, respectively, while germline mutations in CACNA1D cause the rare PASNA syndrome, featuring primary aldosteronism seizures and neurological abnormalities. Further studies are warranted to identify the molecular mechanisms underlying BAH and FH-II, the most common forms of sporadic and familial PA whose molecular basis is yet to be uncovered.
    [Show full text]
  • Diagnosis and Management of Primary Aldosteronism
    review Diagnosis and management of primary aldosteronism Leticia A. P. Vilela1, Madson Q. Almeida1,2 ABSTRACT Primary aldosteronism (PA) is the most common form of secondary hypertension (HTN), with an 1 Unidade de Suprarrenal, estimated prevalence of 4% of hypertensive patients in primary care and around 10% of referred Endocrinologia do patients. Patients with PA have higher cardiovascular morbidity and mortality than age- and sex- Desenvolvimento, Laboratório de matched patients with essential HTN and the same degree of blood pressure elevation. PA is Hormônios e Genética Molecular – LIM42, Divisão de Endocrinologia characterized by an autonomous aldosterone production causing sodium retention, plasma renin e Metabologia, Hospital das supression, HTN, cardiovascular damage, and increased potassium excretion, leading to variable Clínicas, Faculdade de Medicina degrees of hypokalemia. Aldosterone-producing adenomas (APAs) account for around 40% and da Universidade de São Paulo idiopathic hyperaldosteronism for around 60% of PA cases. The aldosterone-to-renin ratio is the (HCFMUSP), São Paulo, SP, Brasil most sensitive screening test for PA. There are several confirmatory tests and the current literature 2 Instituto do Câncer do Estado does not identify a “gold standard” confirmatory test for PA. In our institution, we recommend de São Paulo (Icesp), FMUSP, São Paulo, SP, Brasil starting case confirmation with the furosemide test. After case confirmation, all patients with PA should undergo adrenal CT as the initial study in subtype testing to exclude adrenocortical Correspondence to: carcinoma. Bilateral adrenal vein sampling (AVS) is the gold standard method to define the PA Madson Q. Almeida Unidade de Suprarrenal, subtype, but it is not indicated in all cases.
    [Show full text]
  • A Short Review of Primary Aldosteronism in a Question and Answer Fashion
    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/ by-nc-nd/3.0), which permits copy and redistribute the material in any medium or format, provided the original work is properly cited. ENDOCRINE REGULATIONS, Vol. 52, No. 1, 27–40, 2018 27 doi:10.2478/enr-2018-0005 A short review of primary aldosteronism in a question and answer fashion Frederick-Anthony Farrugia 1, Nicolaos Zavras 2, Georgios Martikos 3, Panagiotis Tzanetis 3, Anestis Charalampopoulos 4, Evangelos P. Misiakos 4, Dimitrios Sotiropoulos 5, Nikolaos Koliakos 5 1General Surgeon, Private practice, Athens, Greece; 2Associate Professor of Pediatric Surgery, Department of Pediatric Surgery, Attikon University Hospital, University of Athens School of Medicine, Athens, Greece; 3Consultant Surgeon, 3rd Department of Surgery, Attikon University Hospital, University of Athens School of Medicine, Athens, Greece; 4Associate Professor Surgery, 3rd Department of Surgery, Attikon University Hospital, University of Athens School of Medicine, Athens, Greece; 5Resident Surgeon, 3rd Department of Surgery, Attikon University Hospital, University of Athens School of Medicine , Athens , Greece E-mail: [email protected] Objectives. The aim of this study was to present up to date information concerning the diag- nosis and treatment of primary aldosteronism (PA). PA is the most common cause of endocrine hypertension. It has been reported up to 24% of selective referred hypertensive patients. Methods. We did a search in Pub-Med and Google Scholar using the terms: PA, hyperaldoste- ronism, idiopathic adrenal hyperplasia, diagnosis of PA, mineralocorticoid receptor antagonists, adrenalectomy, and surgery. We also did cross-referencing search with the above terms.
    [Show full text]
  • Type I Pseudohypoaldosteronism Includes Two Clinically and Genetically Distinct Entities with Either Renal Or Multiple Target Organ Defects
    0021-972X/91/7305-0936$03.00/0 Journal of Clinical Endocrinology and Metabolism Vol. 73, No. 5 Copyright © 1991 by The Endocrine Society Printed in U.S.A. Type I Pseudohypoaldosteronism Includes Two Clinically and Genetically Distinct Entities with either Renal or Multiple Target Organ Defects AARON HANUKOGLU Department of Pediatrics, E. Wolf son Hospital, and Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel ABSTRACT. Type I pseudohypoaldosteronism (PHA) is a transmission with variable expression. hereditary disease characterized by salt wasting resulting from In kindred II, the propositus, who was the product of a target organ unresponsiveness to mineralocorticoids. We have consanguineous marriage, developed severe renal salt losing at studied two kindreds including a total of nine patients with age 9 days. She had also increased salivary and sweat electrolytes PHA. In kindred I, the propositus presented with renal salt consistent with PHA resulting from multiple organ unrespon- wasting in infancy (vomiting, failure to thrive, short stature, siveness to mineralocorticoids. Life threatening episodes of salt hyponatremia, hyperkalemia) and responded dramatically to a wasting recurred beyond the age of 2 yr. At 5 yr of age she still high salt diet (2.5 g/day). Sodium supplementation was discon- requires high amounts of salt supplements (14 g/day). A sister tinued at the age of two. In seven additional family members died at 9 days of age with PHA symptoms. Six close relatives from three generations, clinical expression of PHA varied from (parents, three siblings, maternal uncle) showed no biochemical asymptomatic to moderate. In affected members (propositus, abnormalities.
    [Show full text]
  • Gene Mutations That Promote Adrenal Aldosterone Production, Sodium Retention, and Hypertension
    The Application of Clinical Genetics Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Gene mutations that promote adrenal aldosterone production, sodium retention, and hypertension Andreas G Moraitis1 Abstract: Primary aldosteronism (PA) is the most common form of secondary hypertension, William E Rainey1,2 found in about 5% of all hypertension cases, and up to 20% of resistant hypertension cases. The Richard J Auchus1 most common forms of PA are an aldosterone-producing adenoma and idiopathic (bilateral) hyperaldosteronism. Rare genetic forms of PA exist and, until recently, the only condition 1Division of Metabolism, Endocrinology, and Diabetes, with a known genetic mechanism was familial hyperaldosteronism type 1, also known as Department of Internal Medicine, glucocorticoid-remediable aldosteronism (FHA1/GRA). FHA type 3 has now been shown to 2 Department of Physiology, University derive from germline mutations in the KCNJ5 gene, which encodes a potassium channel found of Michigan, Ann Arbor, MI, USA on the adrenal cells. Remarkably, somatic mutations in KCNJ5 are found in about one-third of aldosterone-producing adenomas, and these mutations are likely to be involved in their pathogenesis. Finally, mutations in the genes encoding an L-type calcium channel (CACNA1D) and in genes encoding a sodium–potassium adenosine triphosphatase (ATP1A1) or a calcium adenosine triphosphatase (ATP2B3) are found in other aldosterone-producing adenomas. These findings provide a working model, in which adenoma formation and/or aldosterone production in many cases derives from increased calcium entry, which drives the pathogenesis of primary aldosteronism. Keywords: hyperaldosteronism, hereditary, potassium channel, calcium channel Introduction: hypertension, its causes and consequences Hypertension, defined as systolic blood pressure (SBP) .140 mmHg, is a physical finding reflecting a variety of genetic and environmental factors, including renal sodium retention and increased vascular resistance.
    [Show full text]